Eviana Health Corporation produces and sells cannabinoid products from natural hemp strains of cannabis sativa for medical, beauty and grooming, vitamins and supplements, fitness, food and beverage, and pet markets.
+ 3 more risks
Imperfect balance sheet and overvalued.
Share Price & News
How has Eviana Health's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: EHC's share price has been volatile over the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: EHC underperformed the Canadian Chemicals industry which returned -7% over the past year.
Return vs Market: EHC underperformed the Canadian Market which returned 10.4% over the past year.
Price Volatility Vs. Market
How volatile is Eviana Health's share price compared to the market and industry in the last 5 years?
Simply Wall St News
7 months ago | Simply Wall StDo Insiders Own Shares In Eviana Health Corporation (CNSX:EHC)?
8 months ago | Simply Wall StHave Insiders Been Selling Eviana Health Corporation (CNSX:EHC) Shares This Year?
10 months ago | Simply Wall StThe Eviana Health (CNSX:EHC) Share Price Is Down 55% So Some Shareholders Are Wishing They Sold
Is Eviana Health undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate EHC's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate EHC's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: EHC is unprofitable, so we can't compare its PE Ratio to the Chemicals industry average.
PE vs Market: EHC is unprofitable, so we can't compare its PE Ratio to the Canadian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate EHC's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: EHC is good value based on its PB Ratio (0.3x) compared to the CA Chemicals industry average (1.3x).
How is Eviana Health forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Materials industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Eviana Health has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Take a look at our analysis of EHC’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
- Eviana Health competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Materials industry.
How has Eviana Health performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: EHC is currently unprofitable.
Growing Profit Margin: EHC is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: EHC is unprofitable, and losses have increased over the past 5 years at a rate of -47.1% per year.
Accelerating Growth: Unable to compare EHC's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: EHC is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-18.6%).
Return on Equity
High ROE: EHC has a negative Return on Equity (-87.79%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
How is Eviana Health's financial position?
Financial Position Analysis
Short Term Liabilities: EHC's short term assets (CA$11.1M) exceed its short term liabilities (CA$2.3M).
Long Term Liabilities: EHC's short term assets (CA$11.1M) exceed its long term liabilities (CA$8.0M).
Debt to Equity History and Analysis
Debt Level: EHC's debt to equity ratio (170%) is considered high.
Reducing Debt: Insufficient data to determine if EHC's debt to equity ratio has reduced over the past 5 years.
Inventory Level: EHC has a high level of physical assets or inventory.
Debt Coverage by Assets: EHC's debt is covered by short term assets (assets are 1.4x debt).
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if EHC has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if EHC has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
What is Eviana Health's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Current dividend yield vs market & industry
Notable Dividend: Unable to evaluate EHC's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate EHC's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if EHC's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if EHC's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of EHC's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Avram Adizes 0
Dr. Avram Adizes, Ph.D., P.E., serves as the Chief Technology Officer of Phoenix Capital Partners Inc. Dr. Adizes is responsible for Technology assessment and evaluation. Dr. Adizes serves as Chairman and ...
CEO Compensation Analysis
Compensation vs Market: Avram's total compensation ($USD0.00) is below average for companies of similar size in the Canadian market ($USD165.67K).
Compensation vs Earnings: Insufficient data to compare Avram's compensation with company performance.
|Chairman of the Board & CEO||2.5yrs||CA$120.00k||7.49% CA$116.4k|
|CFO & Director||6.7yrs||CA$60.00k||0.92% CA$14.3k|
|Member of Advisory Board||1.6yrs||no data||no data|
Experienced Board: EHC's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 27.9%.
Eviana Health Corporation's company bio, employee growth, exchange listings and data sources
- Name: Eviana Health Corporation
- Ticker: EHC
- Exchange: CNSX
- Founded: 2011
- Industry: Specialty Chemicals
- Sector: Materials
- Market Cap: CA$1.553m
- Shares outstanding: 23.90m
- Website: https://eviana.ca
- Eviana Health Corporation
- 5728 East Boulevard
- British Columbia
- V6M 4M4
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|EHC||CNSX (Canadian National Stock Exchange)||Yes||Common Shares||CA||CAD||Sep 2017|
|EVNN.F||OTCPK (Pink Sheets LLC)||Yes||Common Shares||US||USD||Sep 2017|
|1CP||DB (Deutsche Boerse AG)||Yes||Common Shares||DE||EUR||Sep 2017|
Eviana Health Corporation produces and sells cannabinoid products from natural hemp strains of cannabis sativa for medical, beauty and grooming, vitamins and supplements, fitness, food and beverage, and pet markets. It is also involved in the growing of industrial hemp and extraction of cannabidiol. The company was formerly known as C&C Cosmeceuticals Corp. and changed its name to Eviana Health Corporation in May 2017. Eviana Health Corporation was incorporated in 2011 and is headquartered in Vancouver, Canada.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/02/03 01:02|
|End of Day Share Price||2019/11/05 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.